BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19266568)

  • 1. Lactobacillus fermentum CECT 5716 prevents and reverts intestinal damage on TNBS-induced colitis in mice.
    Mañé J; Lorén V; Pedrosa E; Ojanguren I; Xaus J; Cabré E; Domènech E; Gassull MA
    Inflamm Bowel Dis; 2009 Aug; 15(8):1155-63. PubMed ID: 19266568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis.
    Peran L; Camuesco D; Comalada M; Nieto A; Concha A; Adrio JL; Olivares M; Xaus J; Zarzuelo A; Galvez J
    Int J Colorectal Dis; 2006 Dec; 21(8):737-46. PubMed ID: 16052308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactobacillus fermentum ACA-DC 179 displays probiotic potential in vitro and protects against trinitrobenzene sulfonic acid (TNBS)-induced colitis and Salmonella infection in murine models.
    Zoumpopoulou G; Foligne B; Christodoulou K; Grangette C; Pot B; Tsakalidou E
    Int J Food Microbiol; 2008 Jan; 121(1):18-26. PubMed ID: 18077037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes.
    Roselli M; Finamore A; Nuccitelli S; Carnevali P; Brigidi P; Vitali B; Nobili F; Rami R; Garaguso I; Mengheri E
    Inflamm Bowel Dis; 2009 Oct; 15(10):1526-36. PubMed ID: 19504616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis.
    Peran L; Sierra S; Comalada M; Lara-Villoslada F; Bailón E; Nieto A; Concha A; Olivares M; Zarzuelo A; Xaus J; Gálvez J
    Br J Nutr; 2007 Jan; 97(1):96-103. PubMed ID: 17217564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis.
    Peran L; Camuesco D; Comalada M; Nieto A; Concha A; Diaz-Ropero MP; Olivares M; Xaus J; Zarzuelo A; Galvez J
    World J Gastroenterol; 2005 Sep; 11(33):5185-92. PubMed ID: 16127750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of Lactobacillus fermentum BGHI14 with rat colonic mucosa: implications for colitis induction.
    Lukic J; Strahinic I; Milenkovic M; Golic N; Kojic M; Topisirovic L; Begovic J
    Appl Environ Microbiol; 2013 Sep; 79(18):5735-44. PubMed ID: 23851097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling identifies mechanisms of protection to recurrent trinitrobenzene sulfonic acid colitis mediated by probiotics.
    Mariman R; Kremer B; van Erk M; Lagerweij T; Koning F; Nagelkerken L
    Inflamm Bowel Dis; 2012 Aug; 18(8):1424-33. PubMed ID: 22162025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine H2 Receptor-Mediated Suppression of Intestinal Inflammation by Probiotic Lactobacillus reuteri.
    Gao C; Major A; Rendon D; Lugo M; Jackson V; Shi Z; Mori-Akiyama Y; Versalovic J
    mBio; 2015 Dec; 6(6):e01358-15. PubMed ID: 26670383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential intestinal anti-inflammatory effects of Lactobacillus fermentum and Lactobacillus salivarius in DSS mouse colitis: impact on microRNAs expression and microbiota composition.
    Rodríguez-Nogales A; Algieri F; Garrido-Mesa J; Vezza T; Utrilla MP; Chueca N; Garcia F; Olivares M; Rodríguez-Cabezas ME; Gálvez J
    Mol Nutr Food Res; 2017 Nov; 61(11):. PubMed ID: 28752563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotic mixture supplementation in the preventive management of trinitrobenzenesulfonic acid-induced inflammation in a murine model.
    Traina G; Menchetti L; Rappa F; Casagrande-Proietti P; Barbato O; Leonardi L; Carini F; Piro F; Brecchia G
    J Biol Regul Homeost Agents; 2016; 30(3):895-901. PubMed ID: 27655518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superoxide dismutase recombinant Lactobacillus fermentum ameliorates intestinal oxidative stress through inhibiting NF-κB activation in a trinitrobenzene sulphonic acid-induced colitis mouse model.
    Hou CL; Zhang J; Liu XT; Liu H; Zeng XF; Qiao SY
    J Appl Microbiol; 2014 Jun; 116(6):1621-31. PubMed ID: 24484394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of lactococci strains delivering either IL-10 protein or cDNA in a TNBS-induced chronic colitis model.
    del Carmen S; Martín Rosique R; Saraiva T; Zurita-Turk M; Miyoshi A; Azevedo V; de Moreno de LeBlanc A; Langella P; Bermúdez-Humarán LG; LeBlanc JG
    J Clin Gastroenterol; 2014; 48 Suppl 1():S12-7. PubMed ID: 25291117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The viability of Lactobacillus fermentum CECT5716 is not essential to exert intestinal anti-inflammatory properties.
    Rodríguez-Nogales A; Algieri F; Vezza T; Garrido-Mesa N; Olivares M; Comalada M; Riccardi C; Utrilla MP; Rodríguez-Cabezas ME; Galvez J
    Food Funct; 2015 Apr; 6(4):1176-84. PubMed ID: 25700085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent Effectiveness of Multispecies Probiotic Preparations on Intestinal Microbiota Structure Depends on Metabolic Properties.
    Biagioli M; Capobianco D; Carino A; Marchianò S; Fiorucci C; Ricci P; Distrutti E; Fiorucci S
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30717413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the Safety and Efficacy of Lactobacillus plantarum MTCC 5690 and Lactobacillus fermentum MTCC 5689 in Colitis Mouse Model.
    Pradhan D; Singh R; Tyagi A; H M R; Batish VK; Grover S
    Probiotics Antimicrob Proteins; 2019 Sep; 11(3):910-920. PubMed ID: 30484143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotics increase T regulatory cells and reduce severity of experimental colitis in mice.
    Zhao HM; Huang XY; Zuo ZQ; Pan QH; Ao MY; Zhou F; Liu HN; Liu ZY; Liu DY
    World J Gastroenterol; 2013 Feb; 19(5):742-9. PubMed ID: 23430765
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Jang YJ; Kim WK; Han DH; Lee K; Ko G
    Gut Microbes; 2019; 10(6):696-711. PubMed ID: 30939976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bifidobacterium infantis attenuates colitis by regulating T cell subset responses.
    Zuo L; Yuan KT; Yu L; Meng QH; Chung PC; Yang DH
    World J Gastroenterol; 2014 Dec; 20(48):18316-29. PubMed ID: 25561798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation of the intestinal microbiota in the mechanism of beneficial effect of treatment with synbiotic Syngut on experimental colitis under stress conditions.
    Konturek PC; Konturek K; Brzozowski T; Wojcik D; Magierowski M; Targosz A; Krzysiek-Maczka G; Sliwowski Z; Strzalka M; Magierowska K; Szczyrk U; Kwiecien S; Ptak-Belowska A; Neurath M; Dieterich W; Wirtz S; Zopf Y
    J Physiol Pharmacol; 2020 Jun; 71(3):. PubMed ID: 32991312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.